Data on neuraminidase inhibitors were made available [4] (multiple letters)

British Medical Journal

Volumn 328, Issue 7438, 2004, Pages 523-

  Panahloo, Zoya ^a  

^a F Hoffmann La Roche   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; PLACEBO; SIALIDASE INHIBITOR;

ASTHMA; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; FORCED EXPIRATORY VOLUME; HUMAN; INFLUENZA; LABORATORY TEST; LETTER; PRIORITY JOURNAL; TREATMENT OUTCOME;

CHILD; DOUBLE-BLIND METHOD; HUMANS; INFLUENZA, HUMAN; NEURAMINIDASE; RANDOMIZED CONTROLLED TRIALS;

EID: 1442348060     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (1)

1. Symmonds M, Matheson NJ, Harnden A. Guidelines on neuraminidase inhibitors in children are not supported by evidence. BMJ 2004;328:227. (24 January.)